Jeremy Miller, CEO of Health E-Commerce, spoke with Chief Executive about the healthcare industry’s ongoing challenge to controlling costs and competing with Amazon.
United, Starbucks and Amazon taught CEOs in 2018 they should be on the alert because corporate scandals can work against them in many ways.
The Martin Act in New York is a pretty broad mandate, perfectly suited for an AG who wants to attack a politically unpopular company—or an entire industry.
Chief Executive Magazine looks back over a tumultuous and disruptive year for business. The list of things that mattered the most starts with Trump, Bezos, and Musk, not surprisingly.
The story of how CEOs view President Trump took a sharp turn in 2018, as the good feelings from last year’s tax reform faded away and his contentious style of politics became a greater source of anxiety.
Google's CEO spoke to a somewhat dour but relaxed group of Congressmen on a variety of subjects pertaining to the tech giant. But the real story may be what the hearing failed to address.
The National Association of Manufacturers is going after proxy advisory firms and activist shareholders that organization members believe have compiled too much power to affect the fortunes of manufacturing companies .
A recent case involving Johnson & Johnson shows how lawyers will run ads to sway juries against companies in lawsuits. Here’s what you have to know.
Arguments that regulating high-tech will crater the companies aren’t as compelling as the tech titans will have us believe.
Anthony Tabasso, CEO of KVK Tech, talks with Chief Executive about the challenges in manufacturing a controlled substance, a highly-regulated industry, and manufacturing generic medications with lower price pressure.